Today: 9 June 2026
Rolls-Royce Holdings plc Expands Poland Defence Bet With PGZ as Europe Rearms
9 March 2026
1 min read

Rolls-Royce Holdings plc Expands Poland Defence Bet With PGZ as Europe Rearms

London, March 9, 2026, 21:12 GMT

Rolls-Royce Holdings plc on Monday announced it has inked a preliminary agreement with Poland’s Polska Grupa Zbrojeniowa (PGZ) aimed at ramping up collaboration on propulsion systems for military vehicles and naval vessels, giving the British engineering firm a bigger foothold in Europe’s rearmament efforts. Under the proposed partnership, the companies may tackle everything from maintenance and upgrades of existing mtu systems to manufacturing complete drive units and components on Polish soil.

Timing is key here. According to data out Monday from SIPRI, Europe has overtaken other regions as the largest importer of arms for the 2021-25 period. Just last week, Poland’s parliament signed off on a plan to unlock 43.7 billion euros ($51.6 billion) in EU military loans. That surge in European buying “pushed global arms transfers up almost 10 per cent,” said SIPRI arms-transfer director Mathew George. Reuters

That fits for Rolls. Growth lately has been fueled by exactly those areas. On Feb. 26, the company pointed to a boost in its power-systems unit, crediting increased naval budgets and a surge in data-centre demand. Rolls also raised its medium-term guidance, after it posted 2025 adjusted operating profit of 3.46 billion pounds—a metric that excludes certain one-off costs.

Rolls said it’s struck a memorandum of understanding—a first-step cooperation deal—covering both military vehicle propulsion and marine engines. The company’s mtu power-systems brand is already in service with Poland’s armed forces and inside the Borsuk armored vehicle. Paul Röck of Rolls-Royce Power Systems called the group a “reliable partner” for the Polish military. Rolls-Royce

PGZ, the Polish defence company with partial state backing, said the deal could pave the way for domestic production of spare parts and components, and possibly slot some Polish sites into the Rolls-Royce supply chain. Andreas Görtz described PGZ’s move as “recognition of our collaboration to date.” PGZ’s Arkadiusz Bąk added, “the idea of localisation is taking shape here.” Rolls-Royce

Ramped-up spending has boosted suppliers spanning aerospace, engines, and electronics—think BAE Systems, Rheinmetall—while governments across Europe hike budgets and restock arsenals. Rolls, for its part, is targeting that surge in demand with engines, propulsion, and service contracts, steering clear of full weapons systems.

The agreement in Poland isn’t a binding commitment yet. No financial details came out, and the country’s push for EU defence loans is still up in the air with President Karol Nawrocki keeping quiet on a possible veto. Rolls, for its part, continues to flag ongoing supply-chain pressures in aerospace.

Rolls-Royce Power Systems counts government business among its five key growth areas, according to the company. The move announced Monday marks another step away from the civil aviation focus and deeper into defence and power, sectors where Rolls is already seeing growing demand.

Stock Market Today

  • $150M Cancer Proteomics Deal Spurs New NYSE Listing
    June 9, 2026, 9:34 AM EDT. A $150 million deal in functional proteomics, the study of protein functions and interactions critical for drug development, has led to the spin-out of a new company set to list on the New York Stock Exchange (NYSE). The company focuses on advanced cancer treatments including antibody-drug conjugates-targeted therapies combining antibodies with cell-killing agents to attack tumors precisely. Immunotherapies and targeted therapies featured in the pipeline aim to harness and guide the immune system to combat cancer effectively. Filing of the registration statement with regulators marks a key step toward public investment, enabling transparency. This development highlights the growing financial and clinical importance of proteomics in oncology and the biotech sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
NIO Inc Earnings Preview: China EV Maker Faces Crucial Margin Test After Rare Profit Alert
Previous Story

NIO Inc Earnings Preview: China EV Maker Faces Crucial Margin Test After Rare Profit Alert

Rio Tinto plc Drawn Into Hormuz Supply Shock as Amrun Bauxite Cargo Turns Toward China
Next Story

Rio Tinto plc Drawn Into Hormuz Supply Shock as Amrun Bauxite Cargo Turns Toward China

Go toTop